A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer

OBJECTIVE: To evaluate the value of serum complement component 1q (C1q) levels in predicting the efficacy of combined immunotherapy in patients with lung cancer. METHODS: A total of 42 patients with lung cancer who received combined immunotherapy in the cancer center of Renmin Hospital of Wuhan Univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Daoming, Li, Yuan, Li, Haoyue, Tang, Tian, Zheng, Yongfa, Guo, Xufeng, Xu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439965/
https://www.ncbi.nlm.nih.gov/pubmed/34531687
http://dx.doi.org/10.2147/CMAR.S314369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439965/
https://www.ncbi.nlm.nih.gov/pubmed/34531687
http://dx.doi.org/10.2147/CMAR.S314369

Ejemplares similares